Theranos, the beleaguered Palo Alto blood-testing company, is being accused of securities fraud by a major investor who has sued contending “myriad deceptions, falsehoods and fraudulent conduct.” Partner Fund Management, a San Francisco hedge fund, filed the lawsuit Monday in the Delaware Chancery Court, according to a letter sent to its investors....